Melanie S. Brenner, PharmD, BCPS
Articles
June 21st 2017
All-Cause Costs Increase Exponentially with Increased Chronic Kidney Disease Stage
Ladan Golestaneh, MD, MS Paula J. Alvarez, RPh, MPH, MBA Nancy L. Reaven, MA Susan E. Funk, MBA, FACHE Karen J. McGaughey, PhD Alain Romero, PhD Melanie S. Brenner, PharmD, BCPS Macaulay Onuigbo, MD, MSc, MBA
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: August 28th 2024 | Updated: September 8th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: August 4th 2024 | Updated: September 8th 2024
Who Should Have Lp(a) Levels Tested? Experts Take Sides
Published: September 3rd 2024 | Updated: September 8th 2024
ASCERTAIN Data: Oral Decitabine-Cedazuridine Outcomes in MDS
Published: September 3rd 2024 | Updated: September 8th 2024
Luspatercept in Lower Risk MDS: Insights on the COMMANDS Trial
Published: August 28th 2024 | Updated: September 8th 2024
TYK2 Inhibitor Zasocitinib Shows High Efficacy, Safety in Moderate to Severe Psoriasis
